Silverfleet in $675m medical exitSterigenics is being acquired by Chicago-based GTCR, which has just closed Fund IX on $3.25bn.ByToby Mitchenall5 January 2013•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsAsia-PacificEast AsiaNorth AmericaWestern Europe